CHAD WOOD: Open Payments
NPI 1477646875 · FALLON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 9 payments from 9 companies in 2025. Trend: 2023 $324 · 2024 $523 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $138 |
| Boston Scientific Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $31 |
| Indivior Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Korlym, WaveWriter Alpha Prime 16, VRAYLAR, SUBLOCADE, Veozah, Fluad, BREZTRI, Dexcom G6 Transmitter.
Industry payments across NV — which companies pay providers there.
